Stay updated on Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedThe page version tag was upgraded from v3.6.2 to v3.6.3, signaling a small update to the page’s version without indicating changes to the study details.SummaryDifference0.1%

- Check13 days agoChange DetectedThe page revision stamp was updated from v3.6.0 to v3.6.2, indicating a newer revision of the study page. This appears to reflect maintenance or QC updates rather than changes to study details or outcomes.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice stating no participants are being sought. It also standardizes the Intervention/Treatment label and updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check35 days agoChange DetectedA new revision entry 'Revision: v3.5.5' has been added to the revision history, replacing the previous 'Revision: v3.5.4', indicating a recent update to the page's content or metadata.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now displays a newer revision label (v3.5.4) replacing the previous (v3.5.3), indicating an updated page revision.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page’s displayed system revision/version number was updated from v3.5.2 to v3.5.3, reflecting a change to the website release/renderer rather than study details.SummaryDifference0.1%

Stay in the know with updates to Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.